Healthcare Healthtech & Medtech M&A Transactions

United Therapeutics acquires Thymmune Therapeutics, enhancing its regenerative medicine and cell therapy capabilities with a $300 million deal including earn-outs.

Select Medical Holdings is now privately owned following a $3.9 billion acquisition by Welsh, Carson, Anderson & Stowe, Robert A. Ortenzio, and Martin F. Jackson.

Explore the $2.4 trillion global M&A boom, fueled by AI and megadeals. Discover how companies are transforming operations and building resilience.

Ipsen to acquire Memo Therapeutics AG for up to €700M, gaining a Phase II antibody for BKPyV. Kurma Partners and Eurazeo Group are key stakeholders in this significant biotech deal.

Experity enhances its platform with Exdion Healthcare's AI-driven revenue cycle management, aiming to accelerate reimbursements and cut claim denials for urgent care providers.

South Korea's PharmaResearch buys Cosmetic Group USA (CG USA) to enhance its REJURAN Cosmetics brand's manufacturing and distribution in North America.

Dr. Max, owned by Penta Investments, has acquired Farmacie Italiane for €300 million, significantly growing its Italian pharmacy network to 300 locations.

Caidya

Caidya and Simbec-Orion combine forces, forming a specialized CRO to streamline drug development from early science to global clinical trials.

Avista Healthcare Partners strengthens its healthcare services portfolio with the strategic acquisition of sanotact Group, enhancing capabilities across multiple markets.

Coles

Australian retailer Coles is reportedly negotiating a USD2.76 billion deal with TPG for Greencross Pet Wellness, eyeing expansion in the booming pet care sector.

Vithas is in advanced talks to acquire GenesisCare's Spanish oncology business for €40-50 million, significantly expanding its cancer treatment services.

SteriMax strengthens its Canadian market presence by acquiring Andone Pharmaceuticals, enhancing its healthcare and medical device portfolio. Learn more.

Headlands Research expands its clinical trial network by acquiring Clinical Trials Research, enhancing its capabilities in cardiometabolic and other key therapeutic areas.

Martis Capital takes majority stake in Deerfield Group, a fast-growing healthcare marketing and communications agency. Learn more about the deal.

ALR Technologies to acquire CGM Medical Technology, gaining manufacturing and IP for diabetes management solutions. Deal valued at $45M cash and 200M shares.

Vitaura

Vitaura, a LIAN Group platform, acquires Centro Genesy, boosting its presence in Italy's aesthetic medicine sector to five locations.

Ipsen secures Kartos Therapeutics' navtemadlin in a deal up to $1.75B, enhancing its hemato-oncology pipeline with a promising myelofibrosis treatment.

Private equity targets Portugal's family-owned firms facing succession challenges. Explore key deals and market trends driving investment in this vital economic sector.

G Square Healthcare Private Equity buys 82% of Valtecne for €72.5M from Mainetti family, initiating delisting from Euronext Growth Milan.

Ipsen secures navtemadlin, a novel myelofibrosis therapy, in a deal valued up to $1.3 billion, targeting unmet needs in rare blood cancers.

Agilent Technologies completes Biocare Medical acquisition, enhancing its diagnostics and pathology offerings. Learn about the strategic implications.

Davion Healthcare acquires Humaskan for $60M in cash and stock, expanding its digital health platform and financing capabilities.

Thorne

L Catterton is exploring a $4 billion sale of Thorne, the US supplements maker, with Unilever among interested bidders. Learn more about the deal.

Advent International acquires Japan Wellbeing from MBK Partners, marking its first investment in Japan's rapidly growing home care sector.

Thalia Therapeutics

UK biotech Thalia Therapeutics secures €3.1 million and acquires Sanmirna Therapeutics, enhancing its RNA-based oncology and cardiovascular drug development.

Dental

Metric Capital Partners leads consortium acquiring Dental Company, partnering with Alter Capital and CEO Francisco Ruiz to drive growth in Spain's dental sector.

Boundless Bio

Boundless Bio and Serapha Bio unite in a merger, raising $230 million to pioneer a gene editing therapy for Alpha-1 Antitrypsin Deficiency.

DUOS strengthens its health plan technology platform with the acquisition of Linkwell Health, aiming to enhance member outcomes and operational efficiency.

German firm Stada eyes Cooper Consumer Health in a potential €6 billion deal, signaling significant consolidation in the European healthcare market.

Tredence enhances its healthcare and life sciences analytics services by acquiring KMK Consulting, strengthening its position in a key growth market.

Veeva Systems enhances its life sciences platform with Copli's AI, launching Veeva Falcon MLR to accelerate critical medical, legal, and regulatory content reviews.

CVC Capital Partners may exit Cooper Consumer Health for €6 billion, as CapVest-backed Stada explores acquisition talks. Market consolidation heats up.

Honasa Consumer, Mamaearth's parent, invests ₹135 crore in Fluence Pharma, strengthening its position in India's growing nutraceuticals market.

Withings strengthens its connected health offerings by acquiring Biosency, a specialist in remote respiratory monitoring, aiming for European leadership in digital health.

Abarca Health

Abarca Health and LucyRx merge, creating a powerful independent PBM designed for scale and innovation in serving commercial and government clients.

EBI strengthens its bone healing solutions by acquiring Xstim, integrating innovative wearable technology for spinal fusion and fracture repair. Learn more.

Amplio Spine

Amplio Spine strengthens its medical device offerings by acquiring the KeyLift expandable interlaminar stabilization system from FloSpine, focusing on minimally invasive spinal fusion.

AMN Healthcare strengthens its talent solutions by acquiring ESSENTIAL Leadership Assessment, enhancing executive selection and leadership development for healthcare organizations.

AbbVie nears $10.9 billion deal for Apogee Therapeutics, boosting its inflammatory disease pipeline with a long-acting drug candidate. Industry M&A heats up.

Belmont Medical Technologies strengthens its health IT portfolio by acquiring Arcos, enhancing critical care software for trauma, burn, and transfusion management.